<PubmedArticleSet>
<PubmedArticle>
<MedlineCitation Status="Publisher" Owner="NLM">
<PMID Version="1">34161952</PMID>
<DateRevised>
<Year>2021</Year>
<Month>06</Month>
<Day>23</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1423-0275</ISSN>
<JournalIssue CitedMedium="Internet">
<PubDate>
<Year>2021</Year>
<Month>Jun</Month>
<Day>23</Day>
</PubDate>
</JournalIssue>
<Title>ORL; journal for oto-rhino-laryngology and its related specialties</Title>
<ISOAbbreviation>ORL J Otorhinolaryngol Relat Spec</ISOAbbreviation>
</Journal>
<ArticleTitle>A Randomized, Placebo-Controlled Study to Evaluate the Effect of Bio-Enhanced Turmeric Formulation on Radiation-Induced Oral Mucositis.</ArticleTitle>
<Pagination>
<MedlinePgn>1-11</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1159/000516577</ELocationID>
<Abstract>
<AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Oral mucositis is the most common toxicity of chemoradiotherapy treatment of head and neck cancers. The present study was performed to evaluate the effect of a researched turmeric formulation on oral mucositis in patients receiving chemoradiotherapy for oral cancer.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">This randomized double-blinded placebo-controlled trial included 60 patients with oral cancer who had undergone radical surgery. Patients were equally randomized into 3 arms. Bio-enhanced turmeric formulation (BTF) capsules (low dose [1 g/day] or high dose [1.5 g/day]) or placebo was administered daily for 6 weeks with concurrent chemoradiotherapy. Study endpoints included the impact of the treatment on chemoradiotherapy-induced oral mucositis along with dysphagia, oral pain, dermatitis, and weight loss.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The incidence of grade 3 toxicity of oral mucositis, oral pain, dysphagia, and dermatitis was significantly lower in patients who received BTF than placebo. Twenty-five and 20% patients in BTF 1 g/day (p = 0.011) and 1.5 g/day (p = 0.004) arms, respectively, developed grade 3 oral mucositis compared to 65% patients in the placebo arm. Thirty-five and 30% patients in BTF 1 g/day (p = 0.027) and 1.5 g/day (p = 0.011) arms, respectively, developed grade 3 oral pain compared to 70% patients in the placebo arm. Twenty-five and 20% patients in BTF 1 g/day (p = 0.025) and 1.5 g/day (p = 0.010) arms, respectively, developed grade 3 dysphagia compared to 60% patients in the placebo arm. Ten and 5% patients in BTF 1 g/day (p = 0.114) and 1.5 g/day (p = 0.037) arms. respectively, developed grade 3 dermatitis compared to 30% patients in the placebo arm. Patients under BTF supplementation experienced significantly less weight loss and greater compliance with treatment than placebo.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">BTF (BCM-95®) can significantly reduce chemoradiotherapy-induced severe oral mucositis, dysphagia, oral pain, and dermatitis in oral cancer patients.</AbstractText>
<AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">Clinical Trials Registry, India (Registration No. CTRI) (CTRI/2015/12/006413 dated December 4, 2015).</AbstractText>
<CopyrightInformation>© 2021 S. Karger AG, Basel.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Soni</LastName>
<ForeName>Tej Prakash</ForeName>
<Initials>TP</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiation Oncology, Bhagwan Mahaveer Cancer Hospital and Research Centre, Jaipur, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gupta</LastName>
<ForeName>Anil Kumar</ForeName>
<Initials>AK</Initials>
<AffiliationInfo>
<Affiliation>Department of Surgical Oncology, Bhagwan Mahaveer Cancer Hospital and Research Centre, Jaipur, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sharma</LastName>
<ForeName>Lalit Mohan</ForeName>
<Initials>LM</Initials>
<AffiliationInfo>
<Affiliation>Department of Medical Oncology, Bhagwan Mahaveer Cancer Hospital and Research Centre, Jaipur, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Singhal</LastName>
<ForeName>Harish</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Department of Clinical Trial, Bhagwan Mahaveer Cancer Hospital and Research Centre, Jaipur, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sharma</LastName>
<ForeName>Shantanu</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiotherapy, S.M.S. Medical College and Hospital, Jaipur, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gothwal</LastName>
<ForeName>Ravindra Singh</ForeName>
<Initials>RS</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiotherapy, S.M.S. Medical College and Hospital, Jaipur, India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2021</Year>
<Month>06</Month>
<Day>23</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Switzerland</Country>
<MedlineTA>ORL J Otorhinolaryngol Relat Spec</MedlineTA>
<NlmUniqueID>0334721</NlmUniqueID>
<ISSNLinking>0301-1569</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Bio-enhanced turmeric</Keyword>
<Keyword MajorTopicYN="N">Cancer</Keyword>
<Keyword MajorTopicYN="N">Curcumin</Keyword>
<Keyword MajorTopicYN="N">Mucositis</Keyword>
<Keyword MajorTopicYN="N">Radiotherapy</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2020</Year>
<Month>12</Month>
<Day>16</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2021</Year>
<Month>04</Month>
<Day>14</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2021</Year>
<Month>6</Month>
<Day>23</Day>
<Hour>20</Hour>
<Minute>13</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2021</Year>
<Month>6</Month>
<Day>24</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2021</Year>
<Month>6</Month>
<Day>24</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>aheadofprint</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">34161952</ArticleId>
<ArticleId IdType="pii">000516577</ArticleId>
<ArticleId IdType="doi">10.1159/000516577</ArticleId>
</ArticleIdList>
</PubmedData>
</PubmedArticle>
</PubmedArticleSet>